SAFETY RECALL NOTICE

EPIPEN / EPIPEN Jr. RECALL

The U.S. Food and Drug Administration is alerting consumers of a voluntary recall of specific lots of Mylan’s and Pfizer’s Epipen and Epipen Jr. Auto-Injectors.  This recall is due to two reports of potential defect that could make the device difficult to activate in an emergency.Information may change about this recall so please check Mylan.com/EpiPenRecall for updated information.

Mylan will replace the recalled devices for free and is asking patients to keep their existing product until their replacement product can be secure.  Patients may receive either Epipen Auto-Injector or the authorized generic for Epipen Auto-injector at the pharmacy as a replacement based on availability.

Consumers should contact Mylan at 800-796-3526 or email them at: customer.service@mylan.com  with any questions.

Currently the recalled lots are identified below: